Epperly Melissa B, bought ROIV
June 29, 2026 · Form 4 insider transaction
Epperly Melissa B, bought 17,750 shares of Roivant Sciences Ltd. at $4.46 per share, a transaction worth $79.2K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
17,750
Price
$4.46
Total value
$79.2K
InsiderEpperly Melissa B,
RoleDirector
CompanyRoivant Sciences Ltd. (ROIV)
SecurityCommon Shares
Transaction codeM: Option exercise
Transaction dateJune 29, 2026
Filing dateJuly 1, 2026
Shares owned after34,224
OwnershipDirect
10b5-1 planNo
AmendedNo